Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-06

Clinical Trial Update: Phase II Clinical Study of Contezolid for the Treatment of Bone and Joint Tuberculosis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating contezolid for bone and joint tuberculosis is currently enrolling at Beijing Chest Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Contezolid (contezolid)

Snippet

Sponsor: Beijing Chest Hospital | Conditions: Tuberculosis, Bone | Phase 1, Phase 2 | Status: ENROLLING_BY_INVITATION